info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

June, 2019, Volume 19, 2, pp 14164-14169

Research Article

Research Article

Determining the Effective Role of Chapattis Prepared from Composite Flour Against Lipid Profile of Experimental Subjects

Muhammad Hanif Mughal*

Author Affiliations

Homeopathic clinic, Islamabad, Pakistan

Received: June 21, 2019 | Published: June 27, 2019

Corresponding author: Muhammad Hanif Mughal, Homeopathic clinic, Islamabad, Pakistan

DOI: 10.26717/BJSTR.2019.19.003265

Also View In:

Abstract

The current study was used to examine and assess the role of prepared chapattis against lipid profile of human subjects. Considering lipid profile of subjects, mean values of low density lipoprotein, high density lipoprotein, triglycerides, and total cholesterol in normal subjects were 105.65±6.55, 38.35±2.31, 116.79±7.66 and 165.75±10.43 mg/dL in comparison with subjects (consumed chapattis) 98.94±8.17, 43.16±2.64, 111.03±10.71 and 146.34±15.1 mg/dL accordingly. Similarly, low density lipoprotein concentrations (normal subjects) were enhanced from 103.21±6.39 (0 days) to 106.53±6.59 (30 days) mg/dL in N0 whereas consumption of selected composite flour chapatti group (N1) significantly lowered the LDL level from 104.33±6.46 to 91.33±5.65 mg/dL in same intervals. Moreover, values for high density lipoprotein levels were recorded as 38.70±2.40, 38.35±2.38, 38.00±2.36 mg/dL on 0, 15 and 30 days intervals respectively in normal subjects of control group whilst consumption of selected composite flour chapatti group (N1) exhibited significant increment in high density lipoprotein concentrations from 42.95±2.66 to 43.90±2.72 mg/dL. Conclusively, it was found that prepared chapattis from composite flour have been found effective against lipid profile of human subjects.

Keywords: Cereals; Composite Flour; Chapatti; Lipid Profile

Abbreviations: ANF: Anti-Nutritional Factors; LDL-C: Low-Density Lipoprotein; HDL: High Density Lipoprotein; LPL: Lipoprotein Lipase; LPL: Lipoprotein Lipase

Introduction

Cereals belong to the family Gramineae and grown for their highly nutritious edible part or grain and frequently referred as grains [1]. Cereals have been consumed directly as staple foods and indirectly as feed for livestock long ago. They are considered as important food sources [2] and foods made of cereals are supposed to be a primary energy source, vitamin B and protein, minerals for the population globally. These crops are grown throughout the temperate and tropical regions of the world and full fil the approximately fifty percent food energy requirements of population. Cereals in form of wheat, rice, maize, barley are significant source of minerals and bioactive compounds to dire human requirements [3]. Among cereals, wheat (Triticum aestivum) belongs to family gramineae and is considered second only to rice as the main human food crop [4]. In terms of nutrition, there are multiple research data which indicate the consumption of fiber-based foods are significantly associated with reduction in prevalence of chronic diseases such as metabolic syndrome, cardiovascular complications, obesity, different types of cancers, and diabetes. Combination of different nutrients in wheat flour imparts multiple health perspectives. Several studies indicate that consumption of dietary fibers reduced the weight gain and obesity incidence whereas fiber utilization is also enhanced the satiety and lowered the energy intake [5]. Barley (Hordeum vulgare L.) prevents from cardiovascular disorder via decreasing the cholesterol concentrations and improving the glucose tolerance [6]. The higher level of cholesterol, triglycerides, very low-density lipoprotein, free fatty acids, and decline level of high-density lipoprotein are linked with hyperlipidemia. Barley β- glucan has effect on LDL cholesterol, total cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol [7]. Mechanistically, barley flour markedly lowers the bile acids absorption, eliminates steroids, increases catabolism of cholesterol, reduces lipoprotein cholesterol secretion, enhances secretion of bile acids, and reduces the total body pool of cholesterol [8]. The chickpea (Cicer Arietinum L.) is cultivated in different regions of the world as important grain legume crop.

Moreover, dietary fiber in chickpea significantly lowers the cholesterol level and also contains a variety of anti-nutritional factors (ANF) including amylase and protease inhibitors. Diabetes is a chronic global disease burden affecting a large segment of population, worldwide. Various mechanisms have been involved in the progression of this human syndrome, such as pancreatic β-cell dysfunction, higher concentrations of free fatty acids, insulin resistance, leading to overproduction of reactive oxygen species, as well as pancreatic β-cell deficiency and apoptosis. The diabetes is promoted the cardiovascular disease which is linked with hyperglycemia, obesity, dyslipidemia, glucose intolerance, and hypertension [9]. Chickpea exhibit hypocholesterolemic effect through multiple mechanisms such as suppression of cholesterol and fatty acid synthesis, reduction of low-density lipoprotein (LDL-C) levels, triglycerides, enhancement in high density lipoprotein, and inhibition of intestinal absorption of cholesterol [10]. The administration of wheat bran in diabetic volunteers caused momentous reduction in serum glycosylated protein levels, lipoprotein cholesterol, glycosylated albumin levels, and serum lipids levels as well as also decreased the concentrations of blood glucose [11].

Material and Methods

Procurement of Raw Materials

For research purpose, three types of whole grains (Wheat, Barley, Chickpea) were procured from local market, Faisalabad and then were sifted and cleaned to remove dust, dirt, stalks, and any other undesired materials. The cleaned grains were prepared composite flour to make chapattis (weighed 100±2g). Different types of chapattis were prepared from composite flour by using the different concentrations of cereal grains. On the basis of overall acceptability, glycemic index and glycemic load, T3 was used for further analysis.

Selection Criteria

Normal and hyperglycemic individuals with renal failure and other serious dysfunctions of any major organ were not included in the study.

Bio-Efficacy Studies

In bio-efficacy trials, two parallel studies i.e. normal (study 1) and hyperglycemic (study 2) were conducted each comprising of two groups as described in Tables 1 & 3. Each group comprised of 10 subjects. The human efficacy trial continued for thirty days and blood samples of the participants were collected for biochemical assays at fortnightly basis.

Table 1: Bio-Efficacy Plan.

Table 3: Pooled Means for Effect of Intervals on Lipid Profile of Normal and Hyperglycemic Subjects.

Biochemical Analysis

Lipid Profiles: For the evaluation of lipid profile, levels of low-density lipoprotein, high density Lipoprotein, triglyceride and cholesterol were measured.

Low Density Lipoproteins: Low density lipoproteins in human serum samples were determined by adopting the procedure of Kim et al. [12] (Table 2).

Table 2: Pooled means for effect of treatments on lipid profile of normal and hyperglycemic subjects.

High Density Lipoproteins: High density Lipoprotein (HDL) level was measured by Cholesterols Precipitant Methods as described by Alshatwi et al. [13]

Triglyceride: Triglycerides levels were checked by (GPO–PAP) methods [12].

Cholesterol: Cholesterol levels were measured using CHOD– PAP method as mentioned by Kim et al. [12].

Statistical Analysis

All data regarding end parameters were assessed using ANOVA. To check the level of significance, two factors factorial under completely randomized design was used. For post hoc comparison, least significant difference test was performed [14].

Results

(Table 2) represents the treatment effect in both studies. Pooled means for low density lipoproteins, high density lipoproteins, triglycerides and total cholesterol in normal individuals who did not consumed the composite flour chapatti were 105.65±6.55, 38.35±2.31, 116.79±7.66 and 165.75±10.43 mg/dL respectively. While the pooled means of all respective parameters for lipid profile in normal individuals consuming the treatment were observed as 98.94±8.17, 43.16±2.64, 111.03±10.71 and 146.34±15.1 mg/ dL accordingly. In hyperglycemic individuals not consuming the treatment, the pooled means for respective lipid profile parameters were observed as 134.51±5.08, 41.27±2.20, 153.47±6.2 and 178.74±10.33 mg/dL respectively and in hyperglycemic individuals consuming the treatment, pooled means were 126.18±8.63, 42.37±1.57, 137.58±8.75 and 175.07±11.47 respectively. Pooled means for the effect of intervals on lipid profile of both normal and hyperglycemic individuals are represented in Table 3. Low density lipoproteins level in study 1 at day 0 were observed as 103.77±6.28 which dropped to 98.93±9.83 after 30 days and in study 2, it dropped from 132.77±4.83 to 126.1±11.12 mg/dL after 30 days. High density lipoproteins levels raised in normal subjects from 40.83±3.29 to 40.95±3.91 mg/dL and in hyperglycemic subjects from 40.75±1.90 to 42.95±1.63 mg/dL in 30 days. Levels of triglycerides and total cholesterol in normal study dropped from 121.55±7.39 to 108.23±8.15 mg/dL and 166.3±10.61 to 148.1±16.67 mg/dL respectively after 30 days. In hyperglycemic individuals the level of triglycerides and total cholesterol also lowered from 147.56±5.83 to 142.35±15.43 and from 188.88±6.94 to 168.85±7.03 mg/dL respectively after 30 days.

In Table 4, the mean values for low density lipoprotein in study 1 (normal subjects) were enhanced from 103.21±6.39 (0 days) to 106.53±6.59 (30 days) mg/dL in N0 whereas consumption of selected composite flour chapatti group (N1) significantly lowered the LDL level from 104.33±6.46 to 91.33±5.65 mg/dL in same intervals. Similarly, values for high density lipoprotein levels were recorded as 38.70±2.40, 38.35±2.38, 38.00±2.36 mg/ dL on 0, 15 and 30 days intervals respectively in normal subjects of control group whilst consumption of selected composite flour chapatti group (N1) exhibited significant increment in high density lipoprotein concentrations from 42.95±2.66 to 43.90±2.72 mg/dL. Likewise, momentous enhancement was reported in hyperglycemic subjects of H0 and H1 groups from 39.60±1.48 to 43.40±1.62 mg/ dL and 41.90±1.57 to 42.50±1.59 mg/dL, accordingly. Moreover, mean values for triglycerides concentrations of control group (N0) of normal subjects were recorded as 120.6±7.46, 116.79±7.23, and 112.98±6.99 mg/dL whereas 122.5±7.58, 107.1±6.63 mg/dL and 103.47±6.4 on 0, 15 and 30 days respectively after consuming selected composite flour chapatti group (N1).

Table 4: Lipid Profile of Normal and Hyperglycemic Individuals Treated with Composite Flour Chapatti.

Similarly, significant enhancement was observed in triglycerides levels in control group (H0) from 149.8±5.59 to 156.5±5.84 mg/dL and momentous reduction was observed after consuming selected composite flour chapatti group (H1) from 145.32±5.42 to 128.19±4.78 mg/dL. Likewise, mean values of total cholesterol in normal subjects of group (N0) showed 169.7±10.5 mg/dL at day 0 which reduced to161.8±10.01 after 30 days. The subjects consuming treatment showed reduction from 162.9±10.08 to 134.4±8.32 mg/dL after 30 days whereas the hyperglycemic individuals consuming the treatment showed reduction in total cholesterol from 187.86±7.01 to 165.5±6.17 mg/dL within 30 days’ time interval whereas reduction of total cholesterol in the control hyperglycemic group showed reduction from 189.9±7.08 to 172.2±6.42 mg/dL in the same time period (Table 4).

Discussion

The composite flour preparing by lentils, chickpea and guargum exhibited significant hypocholesterolemic effect in male Sprague Dawley rats for 8 weeks. They observed that consumption of composite flour enriched with 3g/100 g guar gum showed lowest cholesterol levels (82.46 mg/dl) and caused significant reduction (17.2%) in comparison with control. Whilst, low density lipoprotein and triglycerides concentrations were recorded as 29.7% and 28.4% in comparison to control, accordingly. They concluded that presence of dietary fibers mainly lowered the levels of cholesterol, low density lipoproteins, and triglycerides. Following mechanisms are involved in hypocholesterolemic potential of composite flour such as suppression of LDL-C oxidation, proliferation of aortic smooth muscle cells, and maintenance of the physical properties of arterial walls, respectively. They are good source of ferulic, and p-coumaric acids polyphenols to lower lipid levels in experimental subjects [15,16]. In another study conducted by Crujeiras and their co-workers [15], they determined that administration of chickpeabased pulse diet-fed diet significantly lowered the total cholesterol from 215 to 182 mg/dl in experimental subjects [15]. Fiber from chickpea flour exerts hypocholesterolaemic effect via suppressing the synthesis of fatty acids in the liver through fiber fermentation products such as propionate, butyrate, and acetate.

These short chain fatty acids suppress the cholesterol and fatty acid biosynthesis through suppressing the acetate (provides acetyl-CoA) utilization [17]. Moreover, in another study reported that supplementation of chickpea diet to healthy male ‘Sprague– Dawley’ rats and showed significant reductions in low density lipoproteins, triglycerides, and enhancement in high density lipoproteins [18]. Likewise, diets enriched peas (46-62%) and chickpea (49-65·4%) supplemented to Sprague–Dawley’ rats and lowered the levels of plasma cholesterol [19]. The current results are in harmony with the investigations of Rabey et al. [20], they found that supplementation of oat and barley bran are involved to lower the induced hyperlipidemia and hypercholesterolemia in the experimental subjects (male albino rats). They categorized into different four groups each comprised of five rats such as Control (G0), G2 (1.0% cholesterol), G2 (10% oat bran, 1% cholesterol), and G3 (10% barley bran, 1% cholesterol), respectively.

Administration of cholesterol to experimental animals caused significant increment in concentrations of total cholesterol, low density lipoprotein, very low-density lipoprotein, and triglycerides and decreased the levels of high-density lipoproteins. The supplementation of bran and barley significantly lowered the concentrations of tri glycerides, cholesterol, very low-density lipoproteins, and increased the levels of high-density lipoproteins. Conclusively, oat bran and barley bran have been found more effectual to prevent from the hypercholesterolemia complications as compared to control [20]. In hypercholesterolemic male Wistar rats, chickpea flour significantly lowered the total cholesterol, triglycerides, low density lipoproteins and enhanced high-density lipoproteins in the liver. In another study, the administration of chickpea and wheat flour chapattis significantly showed reductions in (serum total cholesterol of 0.25 mmol/L (p 0.01) and low-density lipoprotein-concentrations (0.20 mmol/L). In addition, prepared chapattis also increased the polyunsaturated fatty acids and decreased the monounsaturated fatty acids [21].

Different concentrations of wheat and soy flour (90:10, 80:20, 70:30, and 60:40) supplemented to Wistar rats for 28 days evaluated for biochemical analysis. They found that prepared bread (wheat flour (90%), soy flour (10%)) lowered the markers (low density lipoprotein, cholesterol and triacyl glycerol levels) (Table 2) as compared to the control [22]. Similarly, in another study, wheat and finger millet flour administration to human has been reported to lower the concentrations of cholesterol, triglycerides, low density lipoproteins, and very low-density lipoproteins as well as also enhanced the levels of high-density lipoproteins, respectively. In conclusion, flour has been found significant hypoglycemic agent in human and experimental animals [23]. The previous investigations of Yang and their colleagues, they found that chickpea flour has significant effect on visceral adiposity, dyslipidemia and insulin resistance of experimental volunteers. Experimental subjects were divided into three groups including control group, high fat supplemented diet group, and high fat plus chickpea flour enriched group for 8 months.

They investigated that high fat administrated rats (0·032± 0·004 g/g) showed higher epididymal fat pad weight v. total body weight as compared to control fed diet rats (0·015±0·006g/g) and smaller in high fat plus chickpea flour supplemented rats (0·023±0·007g/g), accordingly. Chickpea flour also showed reduction in levels of triglycerides, cholesterol, low density lipoproteins, very low-density lipoproteins and enhancement in levels of high-density lipoproteins, respectively. In muscle and liver, rats induced high fat diet have higher concentration of triacylglycerol (TAG) whereas supplementation of chickpea flour drastically decreased the levels of TAG as muscle, 39 %; liver, 23 %, respectively. Likewise, the enhancement in lipoprotein lipase (LPL) activity in hepatic TAG lipase and epididymal adipose tissue in liver observed as 23 and 40 % whereas chickpea supplementation to rats were normalized these levels. In addition, chickpea flour also showed reduction in leptin and LPL mRNA content in epididymal adipose tissue [24]. In hypercholesterolemic postmenopausal women, supplementation of soy protein contained 150g isoflavones for 10 weeks prevented from the cardiovascular disorders through decreasing the concentrations of low-density lipoproteins, triglycerides, cholesterol and showed high density lipoproteins & paraoxonase activity increment [25].

The earlier findings of Jenkin and their colleagues, they explicated that high based diet from wheat has been found effective in hyperlipidemic men and women. They found that high protein diet administrated to hyperlipidemic men and women and caused significant reductions in serum LDL oxidation, triglycerides, cholesterol and enhancement in high density lipoproteins, respectively. In addition, high consumption of fruits and vegetables are significant linked with prevention from the cardiovascular risks [26].

Conclusion

Cereals are promising source of bioactive compounds such as dietary fibers, ferulic acid, coumaric acid, and phytonutrients. These compounds have been found as chemo-preventive agent against various human maladies such as cancer insurance, diabetes complications, cardiovascular disorders, obesity, and oxidative stress. Composite flour is due to the presence of glucan that prevent from the hypercholesterolemia through lowering the low-density lipoprotein, triglycerides, and enhancing the concentrations of high-density lipoprotein.

Conflict of Interest

There is no conflict of interest among authors.

References

Research Article

Determining the Effective Role of Chapattis Prepared from Composite Flour Against Lipid Profile of Experimental Subjects

Muhammad Hanif Mughal*

Author Affiliations

Homeopathic clinic, Islamabad, Pakistan

Received: June 21, 2019 | Published: June 27, 2019

Corresponding author: Muhammad Hanif Mughal, Homeopathic clinic, Islamabad, Pakistan

DOI: 10.26717/BJSTR.2019.19.003265

Also View In:

Abstract

The current study was used to examine and assess the role of prepared chapattis against lipid profile of human subjects. Considering lipid profile of subjects, mean values of low density lipoprotein, high density lipoprotein, triglycerides, and total cholesterol in normal subjects were 105.65±6.55, 38.35±2.31, 116.79±7.66 and 165.75±10.43 mg/dL in comparison with subjects (consumed chapattis) 98.94±8.17, 43.16±2.64, 111.03±10.71 and 146.34±15.1 mg/dL accordingly. Similarly, low density lipoprotein concentrations (normal subjects) were enhanced from 103.21±6.39 (0 days) to 106.53±6.59 (30 days) mg/dL in N0 whereas consumption of selected composite flour chapatti group (N1) significantly lowered the LDL level from 104.33±6.46 to 91.33±5.65 mg/dL in same intervals. Moreover, values for high density lipoprotein levels were recorded as 38.70±2.40, 38.35±2.38, 38.00±2.36 mg/dL on 0, 15 and 30 days intervals respectively in normal subjects of control group whilst consumption of selected composite flour chapatti group (N1) exhibited significant increment in high density lipoprotein concentrations from 42.95±2.66 to 43.90±2.72 mg/dL. Conclusively, it was found that prepared chapattis from composite flour have been found effective against lipid profile of human subjects.

Keywords: Cereals; Composite Flour; Chapatti; Lipid Profile

Abbreviations: ANF: Anti-Nutritional Factors; LDL-C: Low-Density Lipoprotein; HDL: High Density Lipoprotein; LPL: Lipoprotein Lipase; LPL: Lipoprotein Lipase